Yayın:
Host variations in SARS-CoV-2 infection

dc.contributor.authorAltiok, Doruk
dc.contributor.authorSavci, Elif Zeynep
dc.contributor.authorOzkara, Busra
dc.contributor.authorAlkan, Kamil
dc.contributor.authorNamdar, Dilara Sultan
dc.contributor.authorTuncer, Gizem
dc.contributor.authorKilinc, Bugrahan Regaip
dc.contributor.authorSuicmez, Evren
dc.contributor.authorCetin, Guneysu
dc.contributor.authorUnal, Sinan
dc.contributor.authorDonmus, Beyza
dc.contributor.authorKaragulleoglu, Zeynep Yagmur
dc.contributor.authorUncuoglu, Dilruba Beyza
dc.contributor.authorTekeli, Cansu
dc.contributor.authorMendi, Hanife Aysegul
dc.contributor.authorBengi, Vahdi Umut
dc.contributor.authorSeval, Guldane Cengiz
dc.contributor.authorKilic, Pelin
dc.contributor.authorAltuntas, Evrim Gunes
dc.contributor.authorDemir-Dora, Devrim
dc.date.accessioned2026-06-27T14:35:04Z
dc.date.issued2021
dc.description.abstractThe novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the Coronavirus Disease of 2019 (COVID-19), and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors -e.g. age, sex, race-, the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible changes can be implemented are the other questions, which are sought to be answered.en
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [18AG020]
dc.description.sponsorshipTUBITAK Intern Researchers (STAR) Program [2247-C]
dc.description.urihttps://doi.org/10.3906/biy-2104-67
dc.identifier.doi10.3906/biy-2104-67
dc.identifier.eissn1303-6092
dc.identifier.endpage424
dc.identifier.issn1300-0152
dc.identifier.issue4
dc.identifier.pubmed34803443
dc.identifier.startpage404
dc.identifier.urihttps://hdl.handle.net/20.500.14981/62357
dc.identifier.volume45
dc.identifier.wos000691376800005
dc.language.isoeng
dc.publisherTubitak Scientific & Technological Research Council Turkey
dc.relation.ispartofTURKISH JOURNAL OF BIOLOGY
dc.rightsopenAccess
dc.subjectAngiotensin-converting enzyme 2 (ACE2)
dc.subjecthost genetics
dc.subjectpolymorphisms
dc.subjectSARS-CoV-2
dc.subjecttoll-like receptors (TLR)
dc.subjecttransmembrane serine protease 2 (TMPRSS2)
dc.subjectACUTE RESPIRATORY SYNDROME
dc.subjectSARS-CORONAVIRUS PATHOGENESIS
dc.subjectDNA METHYLATION
dc.subjectPROSTATE-CANCER
dc.subjectPROMOTER POLYMORPHISM
dc.subjectGENE POLYMORPHISMS
dc.subjectSPIKE PROTEIN
dc.subjectBLOOD-GROUP
dc.subjectACE2
dc.subjectSUSCEPTIBILITY
dc.subjectLife Sciences & Biomedicine - Other Topics
dc.titleHost variations in SARS-CoV-2 infection
dc.typeReview
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar